ISRG Intuitive Surgical, Inc.
Intuitive Surgical, Inc. (ISRG) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 100% planned / 0% discretionary
Largest single sale: $15.8M.
Where they traded
No open-market insider purchase on record.
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Brosius Mark | EVP & Chief Mfg and Supply Cha | Sell 10b5-1 | 25 | $365.79 | $9.1K | 764 −3.2% of holding | |
| Brosius Mark | EVP & Chief Mfg and Supply Cha | Sell 10b5-1 | 23 | $347.66 | $8.0K | 789 −2.8% of holding | |
| Brosius Mark | EVP & Chief Mfg and Supply Cha | Sell 10b5-1 | 23 | $350.20 | $8.1K | 812 −2.8% of holding | |
| Brosius Mark | EVP & Chief Mfg and Supply Cha | Sell 10b5-1 | 46 | $361.23 | $16.6K | 835 −5.2% of holding | |
| Brosius Mark | EVP & Chief Mfg and Supply Cha | Sell 10b5-1 | 77 | $375.57 | $28.9K | 881 −8% of holding | |
| Brosius Mark | EVP & Chief Mfg and Supply Cha | Sell 10b5-1 | 77 | $396.37 | $30.5K | 958 −7.4% of holding | |
| Brosius Mark | EVP & Chief Mfg and Supply Cha | Sell 10b5-1 | 77 | $394.26 | $30.4K | 1,035 −6.9% of holding | |
| Brosius Mark | EVP & Chief Mfg and Supply Cha | Sell 10b5-1 | 77 | $394.00 | $30.3K | 1,112 −6.5% of holding | |
| Brosius Mark | EVP & Chief Mfg and Supply Cha | Sell 10b5-1 | 77 | $390.67 | $30.1K | 1,189 −6.1% of holding | |
| GUTHART GARY S | Director | Sell 10b5-1 | 10,000 | $400.00 | $4.0M | 1,245,679 −0.8% of holding | |
| Ladd Amy L | Director | Sell 10b5-1 | 72 | $393.10 | $28.3K | 179 −28.7% of holding | |
| LOEB GARY | EVP & Chief Legal and Complian | Sell 10b5-1 | 400 | $379.00 | $151.6K | 5,320 −7% of holding | |
| Ladd Amy L | Director | Sell 10b5-1 | 400 | $379.00 | $151.6K | 251 −61.4% of holding | |
| Brosius Mark | EVP & Chief Mfg and Supply Cha | Sell 10b5-1 | 28 | $351.00 | $9.8K | 1,266 −2.2% of holding | |
| Brosius Mark | EVP & Chief Mfg and Supply Cha | Sell 10b5-1 | 28 | $346.83 | $9.7K | 1,294 −2.1% of holding | |
| Brosius Mark | EVP & Chief Mfg and Supply Cha | Sell 10b5-1 | 28 | $360.21 | $10.1K | 1,322 −2.1% of holding | |
| Brosius Mark | EVP & Chief Mfg and Supply Cha | Sell 10b5-1 | 28 | $365.58 | $10.2K | 1,350 −2% of holding | |
| Brosius Mark | EVP & Chief Mfg and Supply Cha | Sell 10b5-1 | 28 | $344.00 | $9.6K | 1,378 −2% of holding | |
| Brosius Mark | EVP & Chief Mfg and Supply Cha | Sell 10b5-1 | 25 | $414.13 | $10.4K | 1,406 −1.7% of holding | |
| Brosius Mark | EVP & Chief Mfg and Supply Cha | Sell 10b5-1 | 23 | $412.16 | $9.5K | 1,431 −1.6% of holding | |
| LOEB GARY | EVP & Chief Legal and Complian | Sell 10b5-1 | 400 | $424.14 | $169.7K | 5,720 −6.5% of holding | |
| Brosius Mark | EVP & Chief Mfg and Supply Cha | Sell 10b5-1 | 23 | $424.14 | $9.8K | 1,454 −1.6% of holding | |
| Brosius Mark | EVP & Chief Mfg and Supply Cha | Sell 10b5-1 | 23 | $421.13 | $9.7K | 1,477 −1.5% of holding | |
| Brosius Mark | EVP & Chief Mfg and Supply Cha | Sell 10b5-1 | 23 | $420.12 | $9.7K | 1,500 −1.5% of holding | |
| Jeddi Iman | SVP & GM da Vinci Platforms & | Sell 10b5-1 | 5,625 | $420.55 | $2.4M | 6,463 −46.5% of holding | |
| Brosius Mark | EVP & Chief Mfg and Supply Cha | Sell 10b5-1 | 18 | $439.80 | $7.9K | 1,523 −1.2% of holding | |
| Brosius Mark | EVP & Chief Mfg and Supply Cha | Sell 10b5-1 | 18 | $446.04 | $8.0K | 1,541 −1.2% of holding | |
| Brosius Mark | EVP & Chief Mfg and Supply Cha | Sell 10b5-1 | 18 | $440.38 | $7.9K | 1,559 −1.1% of holding | |
| Brosius Mark | EVP & Chief Mfg and Supply Cha | Sell 10b5-1 | 18 | $440.70 | $7.9K | 1,577 −1.1% of holding | |
| Brosius Mark | EVP & Chief Mfg and Supply Cha | Sell 10b5-1 | 18 | $422.47 | $7.6K | 1,595 −1.1% of holding | |
| LOEB GARY | EVP & Chief Legal and Complian | Sell 10b5-1 | 400 | $446.95 | $178.8K | 6,120 −6.1% of holding | |
| Ladd Amy L | Director | Sell 10b5-1 | 119 | $463.50 | $55.2K | 120 −49.8% of holding | |
| Ladd Amy L | Director | Sell 10b5-1 | 500 | $473.46 | $236.7K | 239 −67.7% of holding | |
| Curet Myriam | EVP & Chief Medical Officer | Sell 10b5-1 | 105 | $493.95 | $51.9K | None left | |
| Brosius Mark | SVP & Chief Mfg and Supply Cha | Sell 10b5-1 | 645 | $485.01 | $312.8K | 1,613 −28.6% of holding | |
| Brosius Mark | SVP & Chief Mfg and Supply Cha | Sell 10b5-1 | 648 | $490.19 | $317.6K | 2,258 −22.3% of holding | |
| Brosius Mark | SVP & Chief Mfg and Supply Cha | Sell 10b5-1 | 648 | $495.20 | $320.9K | 2,906 −18.2% of holding | |
| Brosius Mark | SVP & Chief Mfg and Supply Cha | Sell 10b5-1 | 2,362 | $498.68 | $1.2M | 3,554 −39.9% of holding | |
| Curet Myriam | EVP & Chief Medical Officer | Sell 10b5-1 | 4,728 | $487.18 | $2.3M | 409 −92% of holding | |
| Brosius Mark | SVP & Chief Mfg and Supply Cha | Sell 10b5-1 | 648 | $488.10 | $316.3K | 5,916 −9.9% of holding | |
| Widman Fredrik | VP Corporate Controller | Sell 10b5-1 | 118 | $487.18 | $57.5K | 1,026 −10.3% of holding | |
| Curet Myriam | EVP & Chief Medical Officer | Sell 10b5-1 | 125 | $492.59 | $61.6K | 5,137 −2.4% of holding | |
| Curet Myriam | EVP & Chief Medical Officer | Sell 10b5-1 | 2,345 | $499.71 | $1.2M | 409 −85.1% of holding | |
| Widman Fredrik | VP Corporate Controller | Sell 10b5-1 | 249 | $499.71 | $124.4K | 909 −21.5% of holding | |
| WADORS PATRICIA L | SVP Chief Human Resources Offi | Sell 10b5-1 | 220 | $499.71 | $109.9K | None left | |
| Curet Myriam | EVP & Chief Medical Officer | Sell 10b5-1 | 421 | $494.96 | $208.4K | 409 −50.7% of holding | |
| Widman Fredrik | VP Corporate Controller | Sell 10b5-1 | 133 | $494.96 | $65.8K | 660 −16.8% of holding | |
| Curet Myriam | EVP & Chief Medical Officer | Sell 10b5-1 | 105 | $494.65 | $51.9K | 830 −11.2% of holding | |
| Curet Myriam | EVP & Chief Medical Officer | Sell 10b5-1 | 126 | $520.02 | $65.5K | None left | |
| GUTHART GARY S 3 fills | Director | Sell 10b5-1 | 27,300 | $530.24 | $14.5M | 15,720 −63.5% of holding | |
| Curet Myriam 2 fills | EVP & Chief Medical Officer | Sell 10b5-1 | 230 | $532.61 | $122.5K | None left | |
| Brosius Mark | See Remarks | Sell 10b5-1 | 464 | $548.49 | $254.5K | 131 −78% of holding | |
| Brosius Mark | SVP & Chief Mfg and Supply Cha | Sell 10b5-1 | 464 | $548.49 | $254.5K | 443 −51.2% of holding | |
| Brosius Mark | SVP & Chief Mfg and Supply Cha | Sell 10b5-1 | 4,500 | $547.36 | $2.5M | 907 −83.2% of holding | |
| Brosius Mark | See Remarks | Sell 10b5-1 | 312 | $547.36 | $170.8K | 595 −34.4% of holding | |
| Curet Myriam | EVP & Chief Medical Officer | Sell 10b5-1 | 104 | $559.90 | $58.2K | None left | |
| GUTHART GARY S | Executive Chair of the Board o | Sell 10b5-1 | 22,806 | $570.89 | $13.0M | 2,694 −89.4% of holding | |
| Curet Myriam | EVP & Chief Medical Officer | Sell 10b5-1 | 125 | $568.99 | $71.1K | None left | |
| Charlton Henry L 5 fills | EVP & Chief Commercial and Mkt | Sell 10b5-1 | 13,731 | $580.00 | $8.0M | 7,787 −63.8% of holding | |
| BARRATT CRAIG H | Director | Sell 10b5-1 | 750 | $580.00 | $435.0K | None left | |
| Miller Brian Edward 2 fills | EVP & Chief Digital Officer | Sell 10b5-1 | 3,500 | $575.00 | $2.0M | 5,758 −37.8% of holding | |
| Curet Myriam | EVP & Chief Medical Officer | Sell 10b5-1 | 105 | $560.00 | $58.8K | None left | |
| Widman Fredrik 2 fills | VP Corporate Controller | Sell 10b5-1 | 2,067 | $550.00 | $1.1M | 473 −81.4% of holding | |
| Curet Myriam | EVP & Chief Medical Officer | Sell 10b5-1 | 125 | $543.00 | $67.9K | None left | |
| Curet Myriam 3 fills | EVP & Chief Medical Officer | Sell 10b5-1 | 7,562 | $548.43 | $4.1M | 353 −95.5% of holding | |
| GUTHART GARY S 3 fills | Executive Chair of the Board o | Sell 10b5-1 | 31,600 | $547.44 | $17.3M | 27,027 −53.9% of holding | |
| Rosa David J. | Chief Executive Officer (CEO) | Sell 10b5-1 | 24,500 | $547.55 | $13.4M | 234,256 −9.5% of holding | |
| BARRATT CRAIG H | Director | Sell 10b5-1 | 2,193 | $548.01 | $1.2M | None left |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.